← Evidence map

RetractedArticleEvidence-based complementary and alternative medicine : eCAM2022

Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression.

Huanyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35664943